Page last updated: 2024-10-22

ambroxol and Cirrhosis, Liver

ambroxol has been researched along with Cirrhosis, Liver in 1 studies

Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.

Research Excerpts

ExcerptRelevanceReference
" Recently, several studies have shown a promising outcome of ambroxol chaperone therapy for the treatment of GD, but its therapeutic role in GD1-associated liver cirrhosis and portal hypertension was not verified."8.12Ambroxol Chaperone Therapy for Gaucher Disease Type I-Associated Liver Cirrhosis and Portal Hypertension: A Case Report. ( Cui, SY; Gao, RP; Zhang, P; Zhang, W; Zheng, MF, 2022)
" Recently, several studies have shown a promising outcome of ambroxol chaperone therapy for the treatment of GD, but its therapeutic role in GD1-associated liver cirrhosis and portal hypertension was not verified."4.12Ambroxol Chaperone Therapy for Gaucher Disease Type I-Associated Liver Cirrhosis and Portal Hypertension: A Case Report. ( Cui, SY; Gao, RP; Zhang, P; Zhang, W; Zheng, MF, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhang, P1
Zheng, MF1
Cui, SY1
Zhang, W1
Gao, RP1

Other Studies

1 other study available for ambroxol and Cirrhosis, Liver

ArticleYear
Ambroxol Chaperone Therapy for Gaucher Disease Type I-Associated Liver Cirrhosis and Portal Hypertension: A Case Report.
    Endocrine, metabolic & immune disorders drug targets, 2022, Volume: 22, Issue:6

    Topics: Ambroxol; Gaucher Disease; Glucosylceramidase; Humans; Hypertension, Portal; Liver Cirrhosis; Male

2022